Marcin Mika, APRN
Psychiatric/Mental Health · Saint Charles, ILNPI 1669734315
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Tris Pharma Inc at 25.7% of the total. That places this record below the midpoint for psychiatric/mental health clinicians in IL, where the typical reported total is $456.
Across 20 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$102
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$66
- AbbVie$54
- Otsuka America Pharmaceutical, Inc.$50
- Corium, LLC$45
- Collegium Pharmaceutical, Inc.$25
- plus $56 from 3 others
What the payments were for
- Food & beverage$399100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 5 | $102 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $66 |
| AbbVie | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Corium, LLC | 3 | $45 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
How this compares
$399 in reported general payments places this provider in the 45th percentile of 922 psychiatric/mental health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 67 | $1,686 |
| Fluoxetine Hcl | 39 | $816 |
| Mirtazapine | 59 | $807 |
| Alprazolam | 126 | $761 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 41 | $738 |
| Lamotrigine | 31 | $657 |
| Trazodone Hcl | 47 | $646 |
| Quetiapine Fumarate | 40 | $573 |
| Lorazepam | 49 | $550 |
| Gabapentin | 24 | $430 |
| Bupropion XlBupropion Hcl | 32 | $373 |
| Sertraline Hcl | 26 | $288 |
| Escitalopram Oxalate | 17 | $277 |
| Aripiprazole | 20 | $271 |
| Clonazepam | 40 | $216 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Saint Charles
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$151K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.